Related Experiment Video
Updated: Jan 19, 2026
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Hepatitis C Virus Structure: Defined by What It Is Not
Altaira D Dearborn1,2, Joseph Marcotrigiano1
1The Protein Expression Laboratory, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.
Insights
Hepatitis C virus (HCV) causes chronic liver disease globally. A new vaccine is urgently needed as current therapies are expensive and do not prevent reinfection, highlighting the need for structural insights into HCV components.
Area of Science:
- Virology
- Hepatology
- Immunology
Background:
- Hepatitis C virus (HCV) infects 70 million worldwide, causing chronic liver disease, cirrhosis, and cancer.
- Rising HCV infections in the US are linked to increased intravenous drug use.
- Existing curative therapies are costly and do not prevent reinfection, necessitating vaccine development.
Purpose of the Study:
- To review structural advancements in understanding the Hepatitis C virus (HCV) virion.
- To elucidate the structure and function of HCV core protein and envelope glycoproteins (E1, E2).
- To examine the structural basis of HCV interaction with host receptors CD81 and SR-BI.
Main Methods:
- Review of existing literature on HCV structure and host interactions.
- Analysis of structural data for HCV virion, core protein, and envelope glycoproteins.
- Examination of studies on host cell receptors (CD81, SR-BI) involved in HCV entry.
Main Results:
- HCV virions are asymmetric and heterogeneous, resembling lipoparticles.
- HCV core protein is unstructured.
- HCV E2 glycoprotein mediates binding to CD81 and SR-BI receptors, while E1 function remains unclear.
Conclusions:
- Structural understanding of HCV components is crucial for vaccine design.
- Targeting E2-receptor interactions may offer therapeutic or preventative strategies.
- Further research into E1's function is needed for a comprehensive understanding of HCV infection.
Abstract:
Hepatitis C virus (HCV) represents an important and growing public health problem, chronically infecting an estimated 70 million people worldwide. This blood-borne pathogen is generating a new wave of infections in the United States, associated with increasing intravenous drug use over the last decade. In most cases, HCV establishes a chronic infection, sometimes causing cirrhosis, end-stage liver disease, and hepatocellular carcinoma. Although a curative therapy exists, it is extremely expensive and provides no barrier to reinfection; therefore, a vaccine is urgently needed. The virion is asymmetric and heterogeneous with the buoyancy and protein content similar to low-density lipoparticles. Core protein is unstructured, and of the two envelope glycoproteins, E1 and E2, the function of E1 remains enigmatic. E2 is responsible for specifically binding host receptors CD81 and scavenger receptor class B type I (SR-BI). This review will focus on structural progress on HCV virion, core protein, envelope glycoproteins, and specific host receptors.
Related Concept Videos
13:04A Protocol for Analyzing Hepatitis C Virus Replication
09:02Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:35Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
04:46Targeting Liver Tumors with Oncolytic Viruses via the Hepatic Artery
10:28A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
07:09Hepatic Progenitor Specification from Pluripotent Stem Cells using a Defined Differentiation System